Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats
Open Access
- 3 November 2011
- journal article
- Published by American Society of Hematology in Blood
- Vol. 118 (18) , 4977-4984
Abstract
Anemia of chronic inflammation (ACI) is the most frequent anemia in hospitalized patients and is associated with significant morbidity. A major underlying mechanism of ACI is the retention of iron within cells of the reticuloendothelial system (RES), thus making the metal unavailable for efficient erythropoiesis. This reticuloendothelial iron sequestration is primarily mediated by excess levels of the iron regulatory peptide hepcidin down-regulating the functional expression of the only known cellular iron export protein ferroportin resulting in blockade of iron egress from these cells. Using a well-established rat model of ACI, we herein provide novel evidence for effective treatment of ACI by blocking endogenous hepcidin production using the small molecule dorsomorphin derivative LDN-193189 or the protein soluble hemojuvelin-Fc (HJV.Fc) to inhibit bone morphogenetic protein-Smad mediated signaling required for effective hepcidin transcription. Pharmacologic inhibition of hepcidin expression results in mobilization of iron from the RES, stimulation of erythropoiesis and correction of anemia. Thus, hepcidin lowering agents are a promising new class of pharmacologic drugs to effectively combat ACI.Keywords
This publication has 52 references indexed in Scilit:
- Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in miceJournal of Clinical Investigation, 2010
- Unexplained Aspects of Anemia of InflammationAdvances in Hematology, 2010
- Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in miceJournal of Clinical Investigation, 2009
- Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of HemochromatosisGastroenterology, 2009
- BMP6 is a key endogenous regulator of hepcidin expression and iron metabolismNature Genetics, 2009
- BMP type I receptor inhibition reduces heterotopic ossificationNature Medicine, 2008
- Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balanceJournal of Clinical Investigation, 2007
- Interleukin-6 induces hepcidin expression through STAT3Blood, 2006